Opentrons Raises $40 Million to Expand AI-Powered Lab Automation
Opentrons raises $40 million to expand AI-powered lab automation
Opentrons Labworks has raised $40 million in Series E funding to scale its AI-powered lab automation platform, which includes robotics and software tools designed to accelerate scientific discovery. The funding will support AI-driven experimental execution, expansion into new markets, and deeper integration into the lab automation ecosystem.
Source: Robotics & Automation News · Read original article ↗
Loading article text…
What the source reports
Publisher-reported claims, with original evidence. These results have not been independently verified by RoboSignal.
Reported numbers
Robot count
>11,000 robots
View original evidence
the physical lab has become a bottleneck. Scientists can use frontier models to generate hypotheses and design experiments far faster than laboratories can test them. Opentrons closes that gap with its Opentrons Flex platform, which includes robots and AI systems that enable experiments to be designed, run, and improved in a continuous loop. Considering its deployment of over 11,000 robots to laboratories in over 80
Open source S3countries
>80
View original evidence
the physical lab has become a bottleneck. Scientists can use frontier models to generate hypotheses and design experiments far faster than laboratories can test them. Opentrons closes that gap with its Opentrons Flex platform, which includes robots and AI systems that enable experiments to be designed, run, and improved in a continuous loop. Considering its deployment of over 11,000 robots to laboratories in over 80
Open source S3
- paper: not_reported
- code: not_reported
- weights: not_reported
- dataset: not_reported
Source excerpts and review record
Automatically extracted; no manual editorial approval recorded.
the physical lab has become a bottleneck. Scientists can use frontier models to generate hypotheses and design experiments far faster than laboratories can test them. Opentrons closes that gap with its Opentrons Flex platform, which includes robots and AI systems that enable experiments to be designed, run, and improved in a continuous loop. Considering its deployment of over 11,000 robots to laboratories in over 80
Open source S3
and our systems are built for AI to run experiments directly. That is why autonomous science is standardizing on Opentrons.” The Series E will fund Opentrons’ next phase of growth in autonomous science, where its AI and robotics systems work together to design, execute and learn from experiments required to achieve its customers’ scientific goals. The company will invest in AI-driven experimental execution, extend it
Open source S5
s automation capabilities, and expand into new markets and geographies. James Flexner, managing partner at Avego, says: “Every AI-driven discovery still has to be tested in a real lab. “Drug developers and AI companies alike are moving experimental work forward toward automated workflows that generate usable data. We see a significant opportunity for autonomous science to converge around Opentrons’ platform.” Additio
Open source S6
nally, the Series E will allow Opentrons to enable faster protocol development through its software and AI, expand capabilities across its robots and instruments, and provide deeper integration of its tools into the broader lab automation ecosystem. With its open platform, global installed base, and more than a decade of laboratory automation experience, Opentrons will continue to empower academic groups, diagnostics
Open source S7
labs, and global pharmaceutical companies worldwide to bring autonomous science to their own benches.
Open source S8
Source：Robotics & Automation News · roboticsandautomationnews.com